Stock Analysis

Kao Full Year 2024 Earnings: In Line With Expectations

TSE:4452
Source: Shutterstock

Kao (TSE:4452) Full Year 2024 Results

Key Financial Results

  • Revenue: JP¥1.63t (up 6.3% from FY 2023).
  • Net income: JP¥107.8b (up 146% from FY 2023).
  • Profit margin: 6.6% (up from 2.9% in FY 2023). The increase in margin was driven by higher revenue.
  • EPS: JP¥232 (up from JP¥94.37 in FY 2023).
revenue-and-expenses-breakdown
TSE:4452 Revenue and Expenses Breakdown February 8th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kao Meets Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.

The primary driver behind last 12 months revenue was the Japan segment contributing a total revenue of JP¥903.9b (56% of total revenue). Notably, cost of sales worth JP¥990.0b amounted to 61% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to JP¥355.5b (67% of total expenses). Explore how 4452's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 3.9% growth forecast for the Personal Products industry in Japan.

Performance of the Japanese Personal Products industry.

The company's shares are up 3.5% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Kao's balance sheet.

Valuation is complex, but we're here to simplify it.

Discover if Kao might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:4452

Kao

Develops and sells hygiene and living care, health and beauty care, life care, cosmetics, and chemical products.

Flawless balance sheet established dividend payer.

Community Narratives

Priced for AI perfection - cracks are emerging
Fair Value US$90.15|44.027% overvalued
ChadWisperer
ChadWisperer
Community Contributor
NVDA Market Outlook
Fair Value US$341.12|61.937% undervalued
NateF
NateF
Community Contributor
Karoon Energy (ASX:KAR) - Buy Baby Buy 🚀
Fair Value AU$5.10|70.294% undervalued
StockMan
StockMan
Community Contributor